Northern Trust
CTNM

Northern Trust’s Contineum Therapeutics CTNM Stock Holding History

Northern Trust’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$861K Buy
65,928
+12,052
+22% +$162K ﹤0.01% 3408
2025
Q4 		$616K Buy
53,876
+4,913
+10% +$56.1K ﹤0.01% 3585
2025
Q3 		$575K Buy
48,963
+23,794
+95% +$192K ﹤0.01% 3603
2025
Q2 		$99.9K Sell
25,169
-58,457
-70% -$254K ﹤0.01% 4111
2025
Q1 		$584K Sell
83,626
-5,636
-6% -$51.3K ﹤0.01% 3514
2024
Q4 		$1.31M Buy
89,262
+26,545
+42% +$420K ﹤0.01% 3258
2024
Q3 		$1.2M Buy
62,717
+43,340
+224% +$831K ﹤0.01% 3276
2024
Q2 		$341K Buy
+19,377
New +$312K ﹤0.01% 3645

Other funds holding CTNM

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Northern Trust's CTNM Position: Q1 2026 in Review

Northern Trust increased its Contineum Therapeutics (CTNM) stake by 22% in Q1 2026, buying an estimated $162K and bringing the position to 65,928 shares worth $861K. The position accounts for ﹤0.01% of the portfolio, ranked #3408.

Northern Trust first reported a position in CTNM in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.31M in Q4 2024. 90 funds tracked by Wall St. Rank hold CTNM as of Q1 2026.

  • Northern Trust held 65,928 shares of Contineum Therapeutics worth $861K as of Q1 2026.
  • Northern Trust bought 12,052 Contineum Therapeutics shares in Q1 2026, an estimated $162K.
  • Contineum Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3408 holding.
  • Northern Trust first reported a position in Contineum Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Northern Trust's Contineum Therapeutics position peaked at $1.31M in Q4 2024.
  • 90 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.